title: Tissue distribution of amino acid- and lipid-brevetoxins after intravenous administration to C57BL/6 mice.
abstract: Brevetoxins produced during algal blooms of the dinoflagellate Karenia are metabolized by shellfish into reduction, oxidation, and conjugation products. Brevetoxin metabolites comprising amino acid- and lipid conjugates account for a large proportion of the toxicity associated with the consumption of toxic shellfish. However, the disposition of these brevetoxin metabolites has not been established. Using intravenous exposure to C57BL/6 mice, we investigated the disposition in the body of three radiolabeled brevetoxin metabolites. Amino acid-brevetoxin conjugates represented by S-desoxy-BTX-B2 (cysteine-BTX-B) and lipid-brevetoxin conjugates represented by N-palmitoyl-S-desoxy-BTX-B2 were compared to dihydro-BTX-B. Tissue concentration profiles were unique to each of the brevetoxin metabolites tested, with dihydro-BTX-B being widely distributed to all tissues, S-desoxy-BTX-B2 concentrated in kidney, and N-palmitoyl-S-desoxy-BTX-B2 having the highest concentrations in spleen, liver, and lung. Elimination patterns were also unique: dihydro-BTX-B had a greater fecal versus urinary elimination, whereas urine was a more important elimination route for S-desoxy-BTX-B2, and N-palmitoyl-S-desoxy-BTX-B2 persisted in tissues and was eliminated equally in both urine and feces. The structures particular to each brevetoxin metabolite resulting from the reduction, amino acid conjugation, or fatty acid addition of BTX-B were likely responsible for these tissue-specific distributions and unique elimination patterns. These observed differences provide further insight into the contribution each brevetoxin metabolite class has to the observed potencies.
authors.affiliation: Marine Biotoxins Program, Center for Coastal Environmental Health and Biomolecular Research, NOAA-National Ocean Service , 219 Fort Johnson Road, Charleston, South Carolina 29412, United States.
authors.forename: Tod A
authors.initials: TA
authors.lastname: Leighfield
authors.forename: Noah
authors.initials: N
authors.lastname: Muha
authors.forename: John S
authors.initials: JS
authors.lastname: Ramsdell
mesh_terms: D061605:Administration, Intravenous; D000818:Animals; D001921:Brain / Q000378:metabolism; D003545:Cysteine / Q000737:chemistry*; D004064:Digestive System / Q000378:metabolism; D005243:Feces / Q000737:chemistry; D007668:Kidney / Q000378:metabolism; D008055:Lipids / Q000737:chemistry*; D008168:Lung / Q000378:metabolism; D008297:Male; D008387:Marine Toxins / Q000097:blood / Q000737:chemistry / Q000493:pharmacokinetics* / Q000652:urine; D008810:Mice, Inbred C57BL; D009132:Muscles / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D009498:Neurotoxins / Q000097:blood / Q000737:chemistry / Q000493:pharmacokinetics* / Q000652:urine; D035964:Oxocins / Q000097:blood / Q000737:chemistry / Q000493:pharmacokinetics* / Q000652:urine; D013154:Spleen / Q000378:metabolism; D013737:Testis / Q000378:metabolism; D014018:Tissue Distribution; D000095702:Polyether Toxins
chemical_list: D003545:Cysteine; D008055:Lipids; D008387:Marine Toxins; D009498:Neurotoxins; D035964:Oxocins; C053342:brevetoxin; D000095702:Polyether Toxins